Reduced Th1 response is associated with lower glycolytic activity in activated peripheral blood mononuclear cells after metabolic and bariatric surgery
- PMID: 33991317
- DOI: 10.1007/s40618-021-01587-4
Reduced Th1 response is associated with lower glycolytic activity in activated peripheral blood mononuclear cells after metabolic and bariatric surgery
Abstract
Background: Obesity promotes cellular immunometabolism changes that trigger the activation of macrophages and lymphocytes, leading to systemic inflammation. Activated leukocytes undergo metabolic reprogramming, increasing glycolytic activity.
Objective: To examine whether the reduction in the inflammatory state associated with bariatric surgery is associated with decreased glycolytic activity in leukocytes. Setting Single-center, prospective observational study.
Methods: This study involved 18 patients with obesity undergoing bariatric surgery. All measurements were performed preoperatively and six months postoperatively. Peripheral blood mononuclear cells and plasma were obtained to determine the glycolytic rate and mitochondrial membrane potential as surrogates of the metabolic switching and high-sensitivity C-reactive protein, adipokines, and CD69 expression as inflammatory and activation markers.
Results: Glycolytic activity engaged by CD3/CD28 activation was reduced six months after bariatric surgery, associated with decreased levels of T helper (Th) 1 and Th17 signature cytokines. An overall reduction in inflammatory markers was observed, which correlated with a higher adiponectin/leptin ratio.
Conclusions: Metabolic and bariatric surgery-induced weight loss leads to reprogramming in T cells' metabolic machinery, resulting in reduced stimulation of glycolysis after activation, which may explain the decrease in systemic inflammation mediated by cytokines such as interferon-γ and interleukin-17A.
Keywords: Activation; Bariatric surgery; Immunemetabolism; Inflammation; Metabolic reprogramming; PBMCs.
© 2021. Italian Society of Endocrinology (SIE).
Similar articles
-
Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.J Clin Endocrinol Metab. 2021 Nov 19;106(12):e4917-e4934. doi: 10.1210/clinem/dgab586. J Clin Endocrinol Metab. 2021. PMID: 34363480
-
Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery.Sci Rep. 2021 Jun 9;11(1):12127. doi: 10.1038/s41598-021-91393-y. Sci Rep. 2021. PMID: 34108550 Free PMC article.
-
Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.Diabetes Metab Res Rev. 2018 Oct;34(7):e3029. doi: 10.1002/dmrr.3029. Epub 2018 Jul 23. Diabetes Metab Res Rev. 2018. PMID: 29883055
-
Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery.Oxid Med Cell Longev. 2019 Dec 6;2019:3940739. doi: 10.1155/2019/3940739. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885787 Free PMC article. Review.
-
The evolution of metabolic/bariatric surgery.Obes Surg. 2014 Aug;24(8):1126-35. doi: 10.1007/s11695-014-1354-3. Obes Surg. 2014. PMID: 25008469 Review.
Cited by
-
Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?Front Immunol. 2021 Jul 21;12:699848. doi: 10.3389/fimmu.2021.699848. eCollection 2021. Front Immunol. 2021. PMID: 34367160 Free PMC article. Review.
-
Assessment of immune function in individuals without and with obesity and normoglycemia, glucose intolerance, or type 2 diabetes: primary findings of the NutrIMM study, a single-arm controlled feeding trial.Am J Clin Nutr. 2025 Jun;121(6):1315-1327. doi: 10.1016/j.ajcnut.2025.03.003. Epub 2025 Apr 22. Am J Clin Nutr. 2025. PMID: 40467164 Free PMC article. Clinical Trial.
-
Central and Peripheral Inflammation: A Common Factor Causing Addictive and Neurological Disorders and Aging-Related Pathologies.Int J Mol Sci. 2023 Jun 13;24(12):10083. doi: 10.3390/ijms241210083. Int J Mol Sci. 2023. PMID: 37373230 Free PMC article. Review.
-
The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone.Front Immunol. 2023 Jan 16;13:1104943. doi: 10.3389/fimmu.2022.1104943. eCollection 2022. Front Immunol. 2023. PMID: 36726994 Free PMC article. Review.
-
Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women.Antioxidants (Basel). 2022 Jun 29;11(7):1302. doi: 10.3390/antiox11071302. Antioxidants (Basel). 2022. PMID: 35883794 Free PMC article.
References
-
- Wang Q, Wu H (2018) T Cells in adipose tissue: critical players in immunometabolism. Front Immunol. https://doi.org/10.3389/fimmu.2018.02509 - DOI - PubMed - PMC
-
- Fuster JJ, Ouchi N, Gokce N, Walsh K (2016) Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res 118:1786–1807. https://doi.org/10.1161/CIRCRESAHA.115.306885 - DOI - PubMed - PMC
-
- McDonnell ME, Ganley-Leal LM, Mehta A, Bigornia SJ, Mott M, Rehman Q et al (2012) B lymphocytes in human subcutaneous adipose crown-like structures. Obes Silver Spring Md 20:1372–1378. https://doi.org/10.1038/oby.2012.54 - DOI
-
- Kuroda M, Sakaue H (2017) Adipocyte death and chronic inflammation in obesity. J Med Investig JMI 64:193–196. https://doi.org/10.2152/jmi.64.193 - DOI
-
- Belizário JE, Faintuch J, Garay-Malpartida M (2018) Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm 2018:2037838. https://doi.org/10.1155/2018/2037838 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials